I founded Dame, a vibrator and sexual wellness company, to improve women's health. But I had to fight to be treated the same ...

The National Police dismantled a clandestine laboratory producing erectile dysfunction drugs and anabolic steroids; 27 people ...

Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) said its stronger Eroxon Intense erectile dysfunction gel has been cleared ...

Quarterly reporting season is upon us once more for ASX-listed healthcare companies, arriving at a notable moment for the ...

According to Chronic Pain Australia, more than 5.4 million of us live with the condition. For such a common ailment, new ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, ...

Shed has announced the execution of a definitive commercial agreement with LTR Pharma, formalizing the companies' partnership to commercialize ROXUS®, LTR Pharma's rapid-onset intranasal treatment for ...

LTR Pharma has taken another step toward the planned US launch of its erectile dysfunction treatment ROXUS, signing a ...

Lately, it may feel like you can't go a day without seeing an ad on TV or online about erectile dysfunction (ED). Despite the attention paid to this condition, many men may be hesitant to talk about ...

(Alliance News) - Futura Medical PLC on Monday said it has struck an agreement with Market Performance Group to distribute Eroxon in the US after ending a deal with Haleon PLC. Last November the ...

Exclusive agreement positions Shed as the only U.S. direct-to-consumer telehealth platform offering ROXUS®. ROXUS® will be available exclusively through Mavrox, Shed's consumer-facing men's health ...

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, host Tylah Tully looks at LTR Pharma (ASX:LTP) first commercial agreement in the United States ...